FDA
label_change
· 2013-03-28
FDA Approved: VECTIBIX — Supplemental Application (Amgen, Inc)
Summary
FDA approved a supplemental application for VECTIBIX (panitumumab) filed by Amgen, Inc. The approval updates the drug's labeling to reflect changes in indicatio…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for VECTIBIX (PANITUMUMAB)